Gastro Medical News about Cholangiocarcinoma

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Use of Antiemetic Agents in Acute Gastroenteritis

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity

5. Medicare pay-for-reporting effort draws fire from frustrated doctors

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009
World Journal of Gastroenterology, 09/23/09

Aljiffry M et al. – Several advances in diagnosis, treatment and palliation of cholangiocarcinoma (CC) have occurred in the last decades. CC is a relatively rare tumor and the main risk factors are: chronic inflammation, genetic predisposition and congenital abnormalities of the biliary tree. While the incidence of intra–hepatic CC is increasing, the incidence of extra–hepatic CC is trending down. The only curative treatment for CC is surgical resection with negative margins. Liver transplantation has been proposed only for selected patients with hilar CC that cannot be resected who have no metastatic disease after a period of neoadjuvant chemo–radiation therapy.

<< Previous
Heritability of Childhood Weight Gain from Birth and Risk Markers...

Next >>
The Impact of Socioeconomic Status on Presentation and Treatment...